SCHEMBL30236239

SCHEMBL30236239

CC(C)(CO)Cc1ccccc1CNC(=O)OC(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 1/20 0.48
KDM4A O75164 1/20 0.47
NAMPT P43490 2/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA7 P43166 1/20 0.41
CA14 Q9ULX7 1/20 0.41
NQO2 P16083 1/20 0.41
MALT1 Q9UDY8 1/20 0.40
IDO1 P14902 1/20 0.40
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HDAC1 Q13547 1/20 0.38
BCHE P06276 1/20 0.38
SYK P43405 1/20 0.38
CTSL P07711 1/20 0.38
CTSB P07858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18322375 1.00 KCNA5 (0.48) KCNA5KDM4ANAMPTHDAC10HDAC6
SCHEMBL30159605 0.88 KCNA5 (0.56) KCNA5KDM4ANAMPTHDAC10HDAC6
SCHEMBL8018113 0.88 KCNA5 (0.56) KCNA5KDM4ANAMPTHDAC10HDAC6
SCHEMBL18733751 0.86 KCNA5 (0.46) KCNA5KDM4ANAMPTHDAC10HDAC6
SCHEMBL18706904 0.85 KCNA5 (0.50) KCNA5KDM4ANAMPTHDAC10HDAC6
SCHEMBL6874894 0.85 KCNA5 (0.52) KCNA5KDM4ANAMPTHDAC10HDAC6
SCHEMBL30454240 0.85 KCNA5 (0.52) KCNA5KDM4ANAMPTHDAC10HDAC6
SCHEMBL20297411 0.83 HPGD (0.45) LMNAL3MBTL1
SCHEMBL7257995 0.82 KCNA5 (0.50) KCNA5KDM4ANAMPTHDAC10HDAC6
SCHEMBL18322695 0.82 KCNA5 (0.43) KCNA5KDM4ANAMPTHDAC10HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3782996-B1 NRF2 REGULATORS GLAXOSMITHKLINE IP DEV LTD (GB) 2024-04-10 EP disclosed
US-20230047296-A1 Nrf2 REGULATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2023-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230047296-A1 Nrf2 REGULATORS NFE2L2, KEAP1, NQO1 KCNA5 4727/4885KDM4A 2295/4885NAMPT 611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.